Publications

Genomic epidemiology of SARS-CoV-2 variants during the first two years of the pandemic in Colombia.

Jimenez-Silva, C; Rivero, R; Douglas, J; Bouckaert, R; Villabona-Arenas, CJ; ATKINS, KE; Gastelbondo, B; Calderon, A; Guzman, C; Echeverri-De la Hoz, D; Muñoz, M; Ballesteros, N; Castañeda, S; Patiño, LH; Ramirez, A; Luna, N; Paniz-Mondolfi, A; Serrano-Coll, H; Ramirez, JD; Mattar, S; Drummond, AJ;

2023

Communications medicine, (2023).3 1 10.1038/s43856-023-00328-3.

Using Age-Specific Values for Pediatric HRQoL in Cost-Effectiveness Analysis: Is There a Problem to Be Solved? If So, How?.

Devlin, NJ; Pan, T; Sculpher, M; JIT, M; Stolk, E; Rowen, D; Van Hout, B; Norman, R;

2023

PharmacoEconomics, (2023).41 10 10.1007/s40273-023-01300-8.

Approaching unsafe limits: climate-related health inequities within and beyond Europe.

Van Daalen, KR; Tonne, C; Borrell, C; Nilsson, M; LOWE, R;

2023

The Lancet regional health. Europe, (2023).31, 10.1016/j.lanepe.2023.100683.

The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countries.

Portnoy, A; CLARK, RA; Weerasuriya, CK; Mukandavire, C; Quaife, M; Bakker, R; Garcia Baena, I; Gebreselassie, N; Zignol, M; JIT, M; WHITE, RG; Menzies, NA;

2023

BMJ global health, (2023).8 7 10.1136/bmjgh-2023-012466.

Quantifying patient- and hospital-level antimicrobial resistance dynamics in Staphylococcus aureus from routinely collected data.

Leclerc, Q; CLEMENTS, A; Dunn, H; Hatcher, J; Lindsay, JA; Grandjean, L; KNIGHT, GM;

2023

Journal of medical microbiology, (2023).72 7 10.1099/jmm.0.001724.

The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling study.

Portnoy, A; Arcand, J-L; CLARK, RA; Weerasuriya, CK; Mukandavire, C; Bakker, R; Patouillard, E; Gebreselassie, N; Zignol, M; JIT, M; WHITE, RG; Menzies, NA;

2023

PLoS medicine, (2023).20 7 10.1371/journal.pmed.1004252.

New tuberculosis vaccines in India: Modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01 E and BCG-revaccination.

Clark, RA; Weerasuriya, CK; Portnoy, A; Mukandavire, C; Quaife, M; Bakker, R; SCARPONI, D; Harris, RC; Rade, K; Mattoo, SK; Tumu, D; Menzies, NA; WHITE, RG;

2023

medRxiv (2023). 10.1101/2023.02.24.23286406.

Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries.

Levin, A; Burgess, C; Shendale, S; Morgan, W; Cw Hutubessy, R; Measles–rubella Eradication Modelling Group,; JIT, M; Measles-rubella Eradication Modelling Group,;

2023

BMJ global health, (2023).8 7 10.1136/bmjgh-2022-011526.

Using agent-based modelling to inform incentive design across three levels of care in the payment for performance (P4P) scheme for childbirth care in Tanzania.

Alibrahim, A; FOSS, A; Mziray, N; Binyaruka, P; Maiba, J; CASSIDY, R; Chalabi, Z; BORGHI, J;

2023

. Abstract accepted for oral presentation (2023).

The 'Holy Grail' for Health Systems Modelling: Hybrid Simulation for Strengthened Evaluation of Complex Interventions.

CASSIDY, R; Alibrahim, A; FOSS, A; Semwanga, AR; Mziray, N; Binyaruka, P; BORGHI, J;

2023

. Abstract accepted for oral presentation (2023).